May 10

Study 309/KEYNOTE-775

Join us May 10th!

event info

Study 309/Keynote-775: A Randomized, Phase 3 Study to Compare the Efficacy and Safety of Lenvatinib with Pembrolizumab vs Treatment of Physician’s Choice in Advanced Endometrial Cancer

Tuesday, May 10, 2022
8:30 am ET

Zoom Video Conference
Website: https://us06web.zoom.us/webinar/register/WN_PqID8VoLQc2Uwppdb9ifCg
  • This event has passed.


Organizer
International Gynecologic Cancer Society

Name: International Gynecologic Cancer Society